Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Microsoft
MSFT
|
+$633M |
| 3 |
Alibaba
BABA
|
+$501M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$484M |
| 5 |
Apple
AAPL
|
+$456M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$622M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$597M |
| 3 |
Comcast
CMCSA
|
+$461M |
| 4 |
UnitedHealth
UNH
|
+$409M |
| 5 |
MXIM
Maxim Integrated Products
MXIM
|
+$343M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Consumer Discretionary | 2.25% |
| 3 | Healthcare | 2.2% |
| 4 | Financials | 2.18% |
| 5 | Industrials | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INZY
7801
DELISTED
Inozyme Pharma
INZY
| $1.09M | ﹤0.01% |
94,466
-76,600
| -45% | -$1.19M |
|
|
OTRK
7802
PUT
DELISTED
Ontrak
OTRK
| $1.09M | ﹤0.01% |
1,212
+270
| +29% | +$482K |
|
7803
ProShares MSCI Transformational Changes ETF
ANEW
$7.76M
| $1.09M | ﹤0.01% |
24,496
+13,327
| +119% | +$619K |
|
7804
iShares iBonds Dec 2028 Term Treasury ETF
IBTI
$1.88B
| $1.09M | ﹤0.01% |
+43,099
| New | +$1.11M |
|
|
NIU
7805
CALL
Niu Technologies
NIU
$203M
| $1.09M | ﹤0.01% |
47,200
-4,400
| -9% | -$117K |
|
7806
PUT
Perdoceo Education
PRDO
$2.04B
| $1.09M | ﹤0.01% |
103,600
+48,600
| +88% | +$547K |
|
7807
Establishment Labs
ESTA
$2.75B
| $1.09M | ﹤0.01% |
15,273
-5,523
| -27% | -$407K |
|
7808
Fidelity Value Factor ETF
FVAL
$1.3B
| $1.09M | ﹤0.01% |
22,910
+10,485
| +84% | +$516K |
|
7809
CALL
OR Royalties Inc
OR
$5.75B
| $1.09M | ﹤0.01% |
97,200
-4,500
| -4% | -$56.3K |
|
7810
Talos Energy
TALO
$2.44B
| $1.09M | ﹤0.01% |
79,267
-59,262
| -43% | -$722K |
|
7811
Unitil
UTL
$980M
| $1.09M | ﹤0.01% |
25,494
+6,598
| +35% | +$330K |
|
|
FFHG
7812
DELISTED
Formula Folios Hedged Growth ETF
FFHG
| $1.09M | ﹤0.01% |
+31,048
| New | +$1.1M |
|
|
ISEE
7813
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.09M | ﹤0.01% |
67,200
+38,800
| +137% | +$422K |
|
7814
AdvanSix
ASIX
$555M
| $1.09M | ﹤0.01% |
27,418
+13,360
| +95% | +$459K |
|
|
CADE
7815
CALL
DELISTED
Cadence Bank
CADE
| $1.09M | ﹤0.01% |
36,600
+12,200
| +50% | +$340K |
|
7816
TechnipFMC
FTI
$27.5B
| $1.09M | ﹤0.01% |
144,765
-62,969
| -30% | -$453K |
|
7817
Advantage Solutions
ADV
$540M
| $1.09M | ﹤0.01% |
5,037
+92
| +2% | +$21.6K |
|
|
PKBO
7818
DELISTED
Peak Bio, Inc. Common Stock
PKBO
| $1.09M | ﹤0.01% |
111,259
-3,725
| -3% | -$36.1K |
|
7819
UVA Unconstrained Medium-Term Fixed Income ETF
FFIU
$52.6M
| $1.09M | ﹤0.01% |
41,238
-10,648
| -21% | -$284K |
|
7820
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
| $1.09M | ﹤0.01% |
41,897
-83,703
| -67% | -$2.18M |
|
|
HAAC
7821
PUT
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
| $1.09M | ﹤0.01% |
111,200
-16,900
| -13% | -$165K |
|
7822
Sphere 3D
ANY
$18M
| $1.09M | ﹤0.01% |
2,613
+2,308
| +757% | +$741K |
|
7823
CALL
Choice Hotels
CHH
$5.08B
| $1.09M | ﹤0.01% |
8,600
+1,900
| +28% | +$227K |
|
7824
CALL
Vanguard Russell 2000 ETF
VTWO
$17.4B
| $1.09M | ﹤0.01% |
12,300
+8,600
| +232% | +$770K |
|
7825
PUT
Axcelis
ACLS
$3.85B
| $1.09M | ﹤0.01% |
23,100
+15,300
| +196% | +$666K |
|
Similar funds
Citadel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.
- Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
- Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
- Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
- Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
- Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
- Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
- Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.